Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
Sign Up to like & getrecommendations! Published in 2020 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-020-07059-w
Abstract: This study aimed to investigate the cost-effectiveness of low-dose rivaroxaban plus aspirin versus aspirin alone for patients with stable cardiovascular diseases in the Taiwan setting. We constructed a Markov model to project the lifetime direct… read more here.
Keywords: plus aspirin; cost; cardiovascular diseases; rivaroxaban plus ... See more keywords
Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial.
Sign Up to like & getrecommendations! Published in 2019 at "American heart journal"
DOI: 10.1016/j.ahj.2019.05.004
Abstract: Patients with a recent acute coronary syndrome (ACS) receiving oral antiplatelets and anticoagulants are at risk for bleeding and subsequent adverse non-bleeding-related events. METHODS In this post hoc analysis, we evaluated 7,392 high-risk patients (median… read more here.
Keywords: acute coronary; plus aspirin; recent acute; risk ... See more keywords
Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta‐analysis
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Reproductive Immunology"
DOI: 10.1111/aji.13219
Abstract: Antiphospholipid syndrome (APS) is one of the treatable causes for pregnant women with recurrent pregnancy loss (RPL). This review compares the efficacy of a few treatment interventions (low‐dose aspirin (LDA), aspirin plus low molecular weight… read more here.
Keywords: antiphospholipid syndrome; pregnancy loss; pregnancy; plus aspirin ... See more keywords
Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "Trials"
DOI: 10.1186/s13063-022-06200-4
Abstract: Background Lumbrokinase has been widely used for patients with acute ischemic stroke (AIS) in China; however, because rigorously designed studies are lacking, safety and efficacy of lumbrokinase in the treatment of acute ischemic stroke remains… read more here.
Keywords: acute ischemic; plus aspirin; ischemic stroke; lumbrokinase plus ... See more keywords
Clopidogrel Plus Aspirin in Patients With Different Types of Single Small Subcortical Infarction
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2021.631220
Abstract: Background: We aim to investigate the effects and safety of clopidogrel plus aspirin in patients with different types of single small subcortical infarction (SSSI) in the Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events… read more here.
Keywords: clopidogrel plus; plus aspirin; sssi pad;
In at-risk patients without CVD, polypill plus aspirin reduced a composite of major CV events at 4.6 y
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Internal Medicine"
DOI: 10.7326/acpj202104200-041
Abstract: SOURCE CITATION Yusuf S, Joseph P, Dans A, et al. Polypill with or without aspirin in persons without cardiovascular disease. N Engl J Med. 2021;384:216-28. 33186492. read more here.
Keywords: patients without; plus aspirin; risk patients; cvd polypill ... See more keywords